{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:38:58Z","timestamp":1791200338860,"version":"4.2.0"},"reference-count":55,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Based on literature, it is possible to hypothesize that multidrug resistance (MDR) and angiogenic phenotypes are linked to each other in human liver cancer cells. Our goal is to assess whether MDR cells trigger angiogenesis and to study the possible molecular mechanisms involved. Conditioned medium from parental drug-sensitive P5 cells (P5-CM) and MDR-positive P1(0.5) cells [P1(0.5)-CM] stimulated human umbilical vein endothelial cells (HUVEC) survival, proliferation, migration, and microtubular structure formation, but P1(0.5)-CM had a significantly greater effect than P5-CM. Cell implants were done in the rabbit avascular cornea to measure angiogenesis in vivo: P1(0.5) cells induced an important neovascular response in rabbit cornea after 1 week, whereas P5 cells had no effect. P1(0.5) and P5 cells produced vascular endothelial growth factor, but only P1(0.5) secreted hepatocyte growth factor (HGF) into the medium, and small interfering RNA specific for MDR1 clearly reduced HGF production in P1(0.5) cells. The transcription factor Ets-1 and the HGF receptor c-Met were up-regulated in P1(0.5) cells and in HUVEC cultured in P1(0.5)-CM. Inducible nitric oxide synthase (iNOS) seemed to play a major role in the proangiogenic effect of P1(0.5), and its inhibition by 1400W blunted the capacity of P1(0.5) cells to stimulate HUVEC proliferation, migration, and Ets-1 expression. In conclusion, these data show that development of MDR and angiogenic phenotypes are linked to each other in MDR cells. HGF production, Ets-1 and c-Met up-regulation, and iNOS expression can be part of the molecular mechanisms that enhance the angiogenic activity of the MDR-positive hepatocellular carcinoma cell line. (Cancer Res 2006; 66(5): 2673-82)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-2290","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:23:23Z","timestamp":1141241003000},"page":"2673-2682","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Hepatocyte Growth Factor and Inducible Nitric Oxide Synthase Are Involved in Multidrug Resistance\u2013Induced Angiogenesis in Hepatocellular Carcinoma Cell Lines"],"prefix":"10.1158","volume":"66","author":[{"given":"Nadia","family":"Lasagna","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Fantappie\u0300","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Solazzo","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Morbidelli","sequence":"additional","affiliation":[{"name":"2Department of Molecular Biology, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Marchetti","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Cipriani","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ziche","sequence":"additional","affiliation":[{"name":"2Department of Molecular Biology, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mazzanti","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Postgraduate School in Oncology, DENOthe, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2022061622134917400_B1","doi-asserted-by":"crossref","unstructured":"Grude P, Conti F, Mennecier D, et al. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis. Cancer Lett\u20082002; 186: 107\u201313.","DOI":"10.1016\/S0304-3835(02)00155-6"},{"key":"2022061622134917400_B2","doi-asserted-by":"crossref","unstructured":"Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE, Hafkemeyer P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology\u20082002; 36: 874\u201384.","DOI":"10.1053\/jhep.2002.35619"},{"key":"2022061622134917400_B3","doi-asserted-by":"crossref","unstructured":"Chenivesse X, Franco D, Brechot C. MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J Hepatol\u20081993; 18: 168\u201372.","DOI":"10.1016\/S0168-8278(05)80243-0"},{"key":"2022061622134917400_B4","doi-asserted-by":"crossref","unstructured":"Leveille-Wwbster CR, Arias IM. The biology of P-glycoproteins. J Membr Biol\u20081995; 143: 89\u2013102.","DOI":"10.1007\/BF00234655"},{"key":"2022061622134917400_B5","doi-asserted-by":"crossref","unstructured":"Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem\u20081993; 62: 385\u2013427.","DOI":"10.1146\/annurev.bi.62.070193.002125"},{"key":"2022061622134917400_B6","doi-asserted-by":"crossref","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell\u20081996; 86: 353\u201364.","DOI":"10.1016\/S0092-8674(00)80108-7"},{"key":"2022061622134917400_B7","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell\u20082000; 100: 57\u201370.","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2022061622134917400_B8","doi-asserted-by":"crossref","unstructured":"Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer\u20082003; 3: 401\u201310.","DOI":"10.1038\/nrc1093"},{"key":"2022061622134917400_B9","doi-asserted-by":"crossref","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med\u20082003; 9: 669\u201376.","DOI":"10.1038\/nm0603-669"},{"key":"2022061622134917400_B10","doi-asserted-by":"crossref","unstructured":"Tomita N, Morishita R, Taniyama Y, et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation\u20082003; 107: 1411\u20137.","DOI":"10.1161\/01.CIR.0000055331.41937.AA"},{"key":"2022061622134917400_B11","doi-asserted-by":"crossref","unstructured":"Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J\u20081995; 9: 919\u201325.","DOI":"10.1096\/fasebj.9.10.7542215"},{"key":"2022061622134917400_B12","doi-asserted-by":"crossref","unstructured":"Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell\u20081996; 87: 1171\u201380.","DOI":"10.1016\/S0092-8674(00)81813-9"},{"key":"2022061622134917400_B13","doi-asserted-by":"crossref","unstructured":"Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol\u20081992; 119: 629\u201341.","DOI":"10.1083\/jcb.119.3.629"},{"key":"2022061622134917400_B14","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun\u20081991; 176: 45\u201351.","DOI":"10.1016\/0006-291X(91)90887-D"},{"key":"2022061622134917400_B15","doi-asserted-by":"crossref","unstructured":"Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC, Welgus HG. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem\u20081996; 271: 24576\u201382.","DOI":"10.1074\/jbc.271.40.24576"},{"key":"2022061622134917400_B16","doi-asserted-by":"crossref","unstructured":"Boix L, Rosa JL, Ventura F, et al. c-Met mRNA overexpression in human hepatocellular carcinoma. Hepatology\u20081994; 19: 88\u201391.","DOI":"10.1002\/hep.1840190115"},{"key":"2022061622134917400_B17","doi-asserted-by":"crossref","unstructured":"Hu Z, Evarts RP, Fujio K, et al. Expression of transforming growth factor \u03b1\/epidermal growth factor receptor, hepatocyte growth factor\/c-Met and acidic fibroblast growth factor\/fibroblast growth factor receptors during hepatocarcinogenesis. Carcinogenesis\u20081996; 17: 931\u20138.","DOI":"10.1093\/carcin\/17.5.931"},{"key":"2022061622134917400_B18","doi-asserted-by":"crossref","unstructured":"Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A\u20081993; 90: 1937\u201341.","DOI":"10.1073\/pnas.90.5.1937"},{"key":"2022061622134917400_B19","doi-asserted-by":"crossref","unstructured":"Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J\u20081990; 9: 2241\u20136.","DOI":"10.1002\/j.1460-2075.1990.tb07394.x"},{"key":"2022061622134917400_B20","doi-asserted-by":"crossref","unstructured":"Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3\/ets and AP-1 sequences. J Biol Chem\u20081996; 271: 10672\u201380.","DOI":"10.1074\/jbc.271.18.10672"},{"key":"2022061622134917400_B21","doi-asserted-by":"crossref","unstructured":"Block KL, Shou Y, Poncz M. An Ets\/Sp1 interaction in the 5 flanking region of the megakaryocyte-specific \u03b1 IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood\u20081996; 88: 2071\u201380.","DOI":"10.1182\/blood.V88.6.2071.bloodjournal8862071"},{"key":"2022061622134917400_B22","doi-asserted-by":"crossref","unstructured":"Doubeikovski A, Uzan G, Doubeikovski Z, et al. Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1\/Spi-1 in UT7-Mpl cells. J Biol Chem\u20081997; 272: 24300\u20137.","DOI":"10.1074\/jbc.272.39.24300"},{"key":"2022061622134917400_B23","doi-asserted-by":"crossref","unstructured":"Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol\u20081996; 169: 522\u201331.","DOI":"10.1002\/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO;2-7"},{"key":"2022061622134917400_B24","doi-asserted-by":"crossref","unstructured":"Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis. J Natl Cancer Inst\u20081998; 90: 1069\u201380.","DOI":"10.1093\/jnci\/90.21.1609"},{"key":"2022061622134917400_B25","doi-asserted-by":"crossref","unstructured":"Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A\u20081995; 92: 4392\u20136.","DOI":"10.1073\/pnas.92.10.4392"},{"key":"2022061622134917400_B26","doi-asserted-by":"crossref","unstructured":"Fantappie\u0300 O, Masini E, Sardi I, et al. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology\u20082002; 35: 843\u201352.","DOI":"10.1053\/jhep.2002.32469"},{"key":"2022061622134917400_B27","doi-asserted-by":"crossref","unstructured":"Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol\u20081998; 38: 97\u2013120.","DOI":"10.1146\/annurev.pharmtox.38.1.97"},{"key":"2022061622134917400_B28","doi-asserted-by":"crossref","unstructured":"Michel T, Feron O. Perspective series: nitric oxide and nitric oxide synthases. J Clin Invest\u20081997; 100: 2146\u201352.","DOI":"10.1172\/JCI119750"},{"key":"2022061622134917400_B29","doi-asserted-by":"crossref","unstructured":"Stefan A, Merriam WG, Ogunfusika MO, et al. p53 and vascular endothelial growth of NOS2-expressing human carcinoma cells. Nat Med\u20081998; 4: 1371\u20136.","DOI":"10.1038\/3957"},{"key":"2022061622134917400_B30","doi-asserted-by":"crossref","unstructured":"Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-markers of tumor angiogenesis [review]. Int J Mol Med\u20081998; 2: 715\u20139.","DOI":"10.3892\/ijmm.2.6.715"},{"key":"2022061622134917400_B31","doi-asserted-by":"crossref","unstructured":"Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst\u20081998; 90: 587\u201396.","DOI":"10.1093\/jnci\/90.8.587"},{"key":"2022061622134917400_B32","doi-asserted-by":"crossref","unstructured":"Cianchi F, Cortesini C, Fantappie\u0300 O, et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res\u20082004; 10: 2694\u2013704.","DOI":"10.1158\/1078-0432.CCR-03-0192"},{"key":"2022061622134917400_B33","doi-asserted-by":"crossref","unstructured":"Park YN, Kim YB, Yang KM, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med\u20082000; 124: 1061\u20135.","DOI":"10.5858\/2000-124-1061-IEOVEG"},{"key":"2022061622134917400_B34","doi-asserted-by":"crossref","unstructured":"Mazzanti R, Messerini L, Monsacchi L, et al. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology\u20081997; 25: 229\u201334.","DOI":"10.1002\/hep.510250142"},{"key":"2022061622134917400_B35","unstructured":"Rahman MA, Dhar DK, Yamaguchi E, et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res\u20082001; 7: 1325\u201332."},{"key":"2022061622134917400_B36","doi-asserted-by":"crossref","unstructured":"Macnab GM, Alexander JJ, Lecatsas G, Bey EM, Urbanowicz JM. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer\u20081976; 34: 509\u201315.","DOI":"10.1038\/bjc.1976.205"},{"key":"2022061622134917400_B37","unstructured":"Mazzanti R, Gatmaitan Z, Croop JM, Shu H, Arias IM. Quantitative image analysis of rhodamine 123 transport by Adriamycin-sensitive and -resistant NIH 3T3 and human hepatocellular carcinoma (Alexander) cells. J Cell Pharmacol\u20081990; 1: 50\u20136."},{"key":"2022061622134917400_B38","doi-asserted-by":"crossref","unstructured":"Garvey EP, Oplinger JA, Furfine ES, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem\u20081997; 272: 4959\u201363.","DOI":"10.1074\/jbc.272.8.4959"},{"key":"2022061622134917400_B39","doi-asserted-by":"crossref","unstructured":"Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest\u20081997; 99: 2625\u201334.","DOI":"10.1172\/JCI119451"},{"key":"2022061622134917400_B40","doi-asserted-by":"crossref","unstructured":"Oda N, Abe M, Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin \u03b23. Cell Physiol\u20081999; 178: 121\u201332.","DOI":"10.1002\/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.0.CO;2-F"},{"key":"2022061622134917400_B41","doi-asserted-by":"crossref","unstructured":"Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A\u20081993; 90: 1937\u201341.","DOI":"10.1073\/pnas.90.5.1937"},{"key":"2022061622134917400_B42","doi-asserted-by":"crossref","unstructured":"Ito Y, Miyoshi E, Takeda T, et al. Expression and possible role of ets-1 in hepatocellular carcinoma. Am J Clin Pathol\u20082000; 114: 719\u201325.","DOI":"10.1309\/RAVV-8NM1-CJB7-GJFR"},{"key":"2022061622134917400_B43","doi-asserted-by":"crossref","unstructured":"Jiang Y, Xu W, Lu J, He F, Yang X. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-Met, and transcription factor Ets-1. Biochem Biophys Res Commun\u20082001; 286: 1123\u201330.","DOI":"10.1006\/bbrc.2001.5521"},{"key":"2022061622134917400_B44","unstructured":"Ozaki I, Mizuta T, Zhao G, et al. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res\u20082000; 60: 6519\u201325."},{"key":"2022061622134917400_B45","doi-asserted-by":"crossref","unstructured":"Xin X, Yang S, Ingle G, et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol\u20082001; 158: 1111\u201320.","DOI":"10.1016\/S0002-9440(10)64058-8"},{"key":"2022061622134917400_B46","doi-asserted-by":"crossref","unstructured":"Van Belle E, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor\/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation\u20081998; 97: 381\u201390.","DOI":"10.1161\/01.CIR.97.4.381"},{"key":"2022061622134917400_B47","doi-asserted-by":"crossref","unstructured":"Hashiya N, Jo N, Aoki M, et al. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation\u20082004; 109: 3035\u201341.","DOI":"10.1161\/01.CIR.0000130643.41587.DB"},{"key":"2022061622134917400_B48","doi-asserted-by":"crossref","unstructured":"Sampath J, Sun D, Kidd VJ, et al. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J Biol Chem\u20082001; 276: 39359\u201367.","DOI":"10.1074\/jbc.M103429200"},{"key":"2022061622134917400_B49","doi-asserted-by":"crossref","unstructured":"Gao CF, Vande Woude GF. HGF\/SF-Met signaling in tumor progression. Cell Res\u20082005; 15: 49\u201351.","DOI":"10.1038\/sj.cr.7290264"},{"key":"2022061622134917400_B50","doi-asserted-by":"crossref","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol\u20082003; 4: 915\u201325.","DOI":"10.1038\/nrm1261"},{"key":"2022061622134917400_B51","doi-asserted-by":"crossref","unstructured":"Shinomiya N, Gao CF, Xie Q, et al. RNA interference reveals that ligand-independent Met activity is required for tumor cell signaling and survival. Cancer Res\u20082004; 64: 7962\u201370.","DOI":"10.1158\/0008-5472.CAN-04-1043"},{"key":"2022061622134917400_B52","doi-asserted-by":"crossref","unstructured":"Wang X, DeFrances MC, Dai Y, et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell\u20082002; 9: 411\u201321.","DOI":"10.1016\/S1097-2765(02)00439-2"},{"key":"2022061622134917400_B53","doi-asserted-by":"crossref","unstructured":"Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol\u20082002; 8: 385\u201392.","DOI":"10.3748\/wjg.v8.i3.385"},{"key":"2022061622134917400_B54","doi-asserted-by":"crossref","unstructured":"Xie Q, Liu KD, Hu MY, Zhou K. SF\/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. World J Gastroenterol\u20082001; 7: 816\u201320.","DOI":"10.3748\/wjg.v7.i6.816"},{"key":"2022061622134917400_B55","doi-asserted-by":"crossref","unstructured":"Shimizu S, Kageyama M, Yasuda M, et al. Stimulation of in vitro angiogenesis by nitric oxide through the induction of transcription factor ETS-1. Int J Biochem Cell Biol\u20082004; 36: 114\u201322.","DOI":"10.1016\/S1357-2725(03)00170-5"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/5\/2673\/2560109\/2673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/5\/2673\/2560109\/2673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:38:29Z","timestamp":1655426309000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/5\/2673\/527100\/Hepatocyte-Growth-Factor-and-Inducible-Nitric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-2290","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}